JP2016512210A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016512210A5 JP2016512210A5 JP2015562121A JP2015562121A JP2016512210A5 JP 2016512210 A5 JP2016512210 A5 JP 2016512210A5 JP 2015562121 A JP2015562121 A JP 2015562121A JP 2015562121 A JP2015562121 A JP 2015562121A JP 2016512210 A5 JP2016512210 A5 JP 2016512210A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- buffer
- hydrate
- amount
- morphine sulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 17
- 238000009472 formulation Methods 0.000 claims 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 9
- GRVOTVYEFDAHCL-RTSZDRIGSA-N morphine sulfate pentahydrate Chemical compound O.O.O.O.O.OS(O)(=O)=O.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O GRVOTVYEFDAHCL-RTSZDRIGSA-N 0.000 claims 7
- 239000000872 buffer Substances 0.000 claims 6
- 239000006172 buffering agent Substances 0.000 claims 6
- 235000002639 sodium chloride Nutrition 0.000 claims 6
- 229960004715 morphine sulfate Drugs 0.000 claims 5
- 239000011780 sodium chloride Substances 0.000 claims 5
- 239000002738 chelating agent Substances 0.000 claims 4
- 239000007951 isotonicity adjuster Substances 0.000 claims 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- 229940123973 Oxygen scavenger Drugs 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 230000035699 permeability Effects 0.000 claims 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims 2
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 claims 2
- OVBJJZOQPCKUOR-UHFFFAOYSA-L EDTA disodium salt dihydrate Chemical compound O.O.[Na+].[Na+].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O OVBJJZOQPCKUOR-UHFFFAOYSA-L 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 2
- 239000007853 buffer solution Substances 0.000 claims 2
- 239000001110 calcium chloride Substances 0.000 claims 2
- 229960002713 calcium chloride Drugs 0.000 claims 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims 2
- 235000011148 calcium chloride Nutrition 0.000 claims 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 2
- 229960002303 citric acid monohydrate Drugs 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 239000011521 glass Substances 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 229960005181 morphine Drugs 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 2
- 229960000999 sodium citrate dihydrate Drugs 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- -1 Only containing Substances 0.000 claims 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 229920002307 Dextran Polymers 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 229960004543 anhydrous citric acid Drugs 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 claims 1
- 229940052299 calcium chloride dihydrate Drugs 0.000 claims 1
- 239000008121 dextrose Substances 0.000 claims 1
- 229940124274 edetate disodium Drugs 0.000 claims 1
- 239000012537 formulation buffer Substances 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- GRPSNTXTTSBKGW-BVGHQBMWSA-J magnesium;potassium;sodium;(3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol;triacetate;chloride Chemical compound [Na+].[Mg+2].[Cl-].[K+].CC([O-])=O.CC([O-])=O.CC([O-])=O.OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O GRPSNTXTTSBKGW-BVGHQBMWSA-J 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000001103 potassium chloride Substances 0.000 claims 1
- 235000011164 potassium chloride Nutrition 0.000 claims 1
- 229960002816 potassium chloride Drugs 0.000 claims 1
- 229940071643 prefilled syringe Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229960002668 sodium chloride Drugs 0.000 claims 1
- 239000001540 sodium lactate Substances 0.000 claims 1
- 235000011088 sodium lactate Nutrition 0.000 claims 1
- 229940005581 sodium lactate Drugs 0.000 claims 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361785218P | 2013-03-14 | 2013-03-14 | |
| US61/785,218 | 2013-03-14 | ||
| PCT/EP2014/054831 WO2014140095A1 (en) | 2013-03-14 | 2014-03-12 | Injectable morphine formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016512210A JP2016512210A (ja) | 2016-04-25 |
| JP2016512210A5 true JP2016512210A5 (enExample) | 2017-06-01 |
| JP6215970B2 JP6215970B2 (ja) | 2017-10-18 |
Family
ID=50288050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015562121A Active JP6215970B2 (ja) | 2013-03-14 | 2014-03-12 | 注射可能なモルヒネ製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (7) | US9072781B2 (enExample) |
| EP (2) | EP2968132B1 (enExample) |
| JP (1) | JP6215970B2 (enExample) |
| CN (2) | CN109125254A (enExample) |
| AU (1) | AU2014230834B9 (enExample) |
| BR (1) | BR112015021586B1 (enExample) |
| CA (1) | CA2902343C (enExample) |
| WO (1) | WO2014140095A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014140095A1 (en) | 2013-03-14 | 2014-09-18 | Becton Dickinson France S.A.S. | Injectable morphine formulations |
| PT2968729T (pt) | 2013-03-14 | 2018-11-06 | Fresenius Kabi Deutschland Gmbh | Sistema de acondicionamento para fármacos sensíveis ao oxigénio |
| CA2968915A1 (en) * | 2014-12-03 | 2016-06-09 | Csl Behring Ag | Pharmaceutical product with increased stability comprising immunoglobulins |
| US20170189352A1 (en) | 2015-03-13 | 2017-07-06 | Par Pharmaceutical, Inc. | Epinephrine formulations |
| US9119876B1 (en) | 2015-03-13 | 2015-09-01 | Par Pharmaceutical, Inc. | Epinephrine formulations |
| US11369700B2 (en) | 2015-05-25 | 2022-06-28 | IGL Pharma Inc. | DOTMP kit formulations for radioisotopes |
| JP6930922B2 (ja) * | 2015-05-25 | 2021-09-01 | アイジーエル ファーマ，インコーポレイティド | 放射性同位体用ｄｏｔｍｐキット製剤 |
| US20180064703A1 (en) | 2016-09-02 | 2018-03-08 | Sun Pharmaceutical Industries Ltd. | Stable infusion dosage form of morphine |
| ES3027562T3 (en) * | 2016-09-23 | 2025-06-16 | Gruenenthal Gmbh | Stable formulation for parenteral administration of tapentadol |
| CA3093725C (en) | 2018-03-23 | 2021-08-24 | Nevakar Inc. | Epinephrine compositions and containers |
| CN114207101B (zh) | 2019-07-31 | 2024-05-31 | 埃科莱布美国股份有限公司 | 免用个人防护设备的脱灰剂组合物 |
| US11806320B2 (en) * | 2020-02-19 | 2023-11-07 | Endo Ventures Limited | Isoproterenol compositions and methods |
| EP4265253A4 (en) * | 2020-12-18 | 2024-11-27 | FUJIFILM Toyama Chemical Co., Ltd. | PHARMACEUTICAL COMPOSITION |
Family Cites Families (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1048712A (en) | 1912-02-23 | 1912-12-31 | John Uri Lloyd | Process of extracting, purifying, or excluding alkaloids and alkaloidal salts. |
| US2715627A (en) | 1952-05-26 | 1955-08-16 | Charles L Mehltretter | Solvent extraction of opium alkaloids |
| US4071620A (en) | 1977-01-10 | 1978-01-31 | American Home Products Corporation | Stabilization of oxygen sensitive dose forms |
| JPS56125876U (enExample) | 1980-02-23 | 1981-09-25 | ||
| US4367738A (en) | 1981-10-28 | 1983-01-11 | Janssen Pharmaceutica Inc. | Pre-filled syringe for abusable drugs |
| EP0106290B1 (en) | 1982-10-08 | 1988-04-06 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Evacuated blood collecting device |
| US4998400A (en) | 1986-03-22 | 1991-03-12 | Material Engineering Technology Laboratory, Incorporated | Medical fluid-filled plastic container and methods of making same |
| JPS6311160A (ja) | 1986-07-02 | 1988-01-18 | 株式会社新素材総合研究所 | 薬液容器収納体及びその製造方法 |
| US5723147A (en) | 1987-02-23 | 1998-03-03 | Depotech Corporation | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
| US5807572A (en) | 1988-02-18 | 1998-09-15 | Depotech Corporation | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
| US5030216A (en) | 1989-12-15 | 1991-07-09 | Alza Corporation | Osmotically driven syringe |
| JP3630436B2 (ja) | 1991-11-13 | 2005-03-16 | 株式会社創研 | 米からの活性酸素消去剤 |
| GB9200219D0 (en) | 1992-01-07 | 1992-02-26 | Medimech Int Ltd | Automatic injectors |
| EP0673261A4 (en) | 1992-12-14 | 1997-11-26 | Mallinckrodt Medical Inc | PROCESSES FOR PRODUCING PRE-FILLED LIQUID DELIVERY DEVICES WITHOUT EXTERNAL OR INTERNAL CONTAMINATION. |
| CA2120197A1 (en) * | 1993-04-02 | 1994-10-03 | Kenji Endo | Stable aqueous dispersions containing liposomes |
| US5414049A (en) | 1993-06-01 | 1995-05-09 | Howmedica Inc. | Non-oxidizing polymeric medical implant |
| SE9401986D0 (sv) | 1994-06-08 | 1994-06-08 | Pharmacia Ab | New process for sterilization and articles sterilized thereby |
| US5624402A (en) | 1994-12-12 | 1997-04-29 | Becton, Dickinson And Company | Syringe tip cap |
| US6196998B1 (en) | 1994-12-12 | 2001-03-06 | Becton Dickinson And Company | Syringe and tip cap assembly |
| US5931809A (en) | 1995-07-14 | 1999-08-03 | Depotech Corporation | Epidural administration of therapeutic compounds with sustained rate of release |
| US6054584A (en) | 1996-11-19 | 2000-04-25 | The Board Of Regents Of The University And Community College System Of Neveda | Process for extracting and purifying morphine from opium |
| SE9601348D0 (sv) | 1996-04-10 | 1996-04-10 | Pharmacia Ab | Improved containers for parenteral fluids |
| KR100304846B1 (ko) | 1996-06-17 | 2001-09-24 | 오쓰카 요시미쓰 | 중탄산염 함유 약액 용기 포장체 및 피에이치인디케이터ㅔ |
| CA2258965A1 (en) | 1996-06-28 | 1998-01-08 | Oxigene, Inc. | Useful formulations of acid addition salt drugs |
| US5997899A (en) | 1996-10-01 | 1999-12-07 | Skyepharma Inc. | Method for producing liposomes with increased percent of compound encapsulated |
| JPH10182687A (ja) | 1996-10-21 | 1998-07-07 | Bayer Yakuhin Kk | アカルボースの貯蔵安定化法 |
| DE69729663T2 (de) | 1996-12-16 | 2005-07-07 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Kanüle mit stumpfen ende und zugangszapfen |
| US5891467A (en) | 1997-01-31 | 1999-04-06 | Depotech Corporation | Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes |
| WO1998045191A1 (en) | 1997-04-10 | 1998-10-15 | Johns Hopkins University | Gaz syringe and package therefor |
| JPH1147274A (ja) | 1997-06-03 | 1999-02-23 | Takeda Chem Ind Ltd | ２室型注射器及び２室型注射器用接続具 |
| WO1999022691A1 (en) | 1997-10-31 | 1999-05-14 | Abbott Laboratories | System for storing oxygen sensitive compositions |
| US6200627B1 (en) | 1998-03-17 | 2001-03-13 | Becton, Dickinson And Company | Low silicone glass prefillable syringe |
| US6361524B1 (en) | 1998-04-14 | 2002-03-26 | Becton, Dickinson And Company | Syringe assembly |
| US6217550B1 (en) | 1998-07-29 | 2001-04-17 | Becton, Dickinson And Company | Single-use syringe |
| US6333087B1 (en) | 1998-08-27 | 2001-12-25 | Chevron Chemical Company Llc | Oxygen scavenging packaging |
| AU6046900A (en) * | 1999-06-16 | 2001-01-02 | Nastech Pharmaceutical Company, Inc | Method for increasing the solubility of morphine and pharmaceutical compositionsprepared therefrom |
| US7137968B1 (en) | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
| US6875400B2 (en) | 2000-12-22 | 2005-04-05 | Cryovac, Inc. | Method of sterilizing and initiating a scavenging reaction in an article |
| JP2002253641A (ja) | 2001-03-01 | 2002-09-10 | Terumo Corp | プレフィルドシリンジ用注射器包装体 |
| EP1243524A3 (en) | 2001-03-16 | 2004-04-07 | Pfizer Products Inc. | Pharmaceutical kit for oxygen-sensitive drugs |
| EP1241110A1 (en) | 2001-03-16 | 2002-09-18 | Pfizer Products Inc. | Dispensing unit for oxygen-sensitive drugs |
| JP2003052819A (ja) | 2001-08-10 | 2003-02-25 | Seikagaku Kogyo Co Ltd | 薬剤充填注射器包装物およびその滅菌または殺菌方法 |
| CN1607968A (zh) | 2001-11-02 | 2005-04-20 | 梅里迪安医学技术公司 | 药物容器、用于施用药物的药物配送套件及其包装方法 |
| US6870273B2 (en) | 2002-04-29 | 2005-03-22 | Pmc-Sierra, Inc. | High speed I/O pad and pad/cell interconnection for flip chips |
| JP2004057321A (ja) | 2002-07-26 | 2004-02-26 | Shionogi & Co Ltd | 収着酸素が除去されたプラスチック容器 |
| US20060010651A1 (en) | 2002-10-08 | 2006-01-19 | Hiroshi Honda | Lifting device forming structure and chemical container having the structure |
| US20040102476A1 (en) | 2002-11-25 | 2004-05-27 | Chan Tai Wah | High concentration formulations of opioids and opioid derivatives |
| EP1581285B1 (en) | 2002-12-23 | 2009-02-25 | Medtronic, Inc. | Drug solution density adjustment systems and methods |
| EP1589902A1 (en) | 2003-01-27 | 2005-11-02 | Medtronic Vascular Connaught | Improved packaging for stent delivery systems |
| JP2004229750A (ja) | 2003-01-28 | 2004-08-19 | Nipro Corp | プレフィルドシリンジ及びそのバレルの製造方法 |
| JP2006513938A (ja) | 2003-03-25 | 2006-04-27 | メドトロニック ヴァスキュラー コノート | ステント及びステント運搬システムの包装 |
| BRPI0409133B8 (pt) | 2003-04-08 | 2021-05-25 | Progenics Pharm Inc | preparações farmacêuticas estavéis compreendendo metilnaltrexona |
| WO2004093775A1 (ja) | 2003-04-23 | 2004-11-04 | Otsuka Pharmaceutical Factory, Inc. | 薬液充填プラスチックアンプルおよびその製造方法 |
| US20040243214A1 (en) | 2003-04-23 | 2004-12-02 | Medtronic Vascular, Inc. | Coated stent with protective packaging and method of using same |
| FR2855413B1 (fr) | 2003-05-26 | 2005-12-30 | Becton Dickinson France | Seringue pre-remplie avec coiffe anti effraction |
| EP1653930B1 (en) | 2003-08-05 | 2007-12-19 | Zentiva, a.s. | Methods for the stabilization of atorvastatin |
| US20050085785A1 (en) | 2003-10-17 | 2005-04-21 | Sherwin Shang | High impact strength film and non-pvc containing container and pouch and overpouch |
| US20050228336A1 (en) | 2004-04-07 | 2005-10-13 | Preston Keusch | Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability |
| JP4759232B2 (ja) | 2004-07-02 | 2011-08-31 | テルモ株式会社 | 包装されたプレフィルドシリンジの製造方法 |
| CA2574102A1 (en) | 2004-07-16 | 2006-01-26 | Pfizer Products Inc. | Pharmaceutical package for simultaneously maintaining low moisture and low oxygen levels |
| ATE422852T1 (de) | 2004-12-08 | 2009-03-15 | Perfecseal Inc | Sterilisierbares paket mit hoher sauerstoffbarriere |
| KR101231965B1 (ko) | 2005-04-28 | 2013-02-08 | 가부시키가이샤 오츠까 세이야꾸 고죠 | 약액 용기 수용체 및 그 제조 방법 |
| WO2007023736A1 (ja) | 2005-08-22 | 2007-03-01 | Nipro Corporation | プレフィルドシリンジ |
| BRPI0503734A (pt) | 2005-08-23 | 2007-04-27 | Cristalia Prod Quimicos Farm | composição farmacêutica na forma de solução injetável de morfina pronta para uso e forma de dosagem unitária de morfina para administração epidural ou intratecal |
| TWI489984B (zh) | 2006-08-04 | 2015-07-01 | Wyeth Corp | 用於非經腸道傳輸化合物之配方及其用途 |
| JP2008067989A (ja) | 2006-09-15 | 2008-03-27 | Terumo Corp | プレフィルドシリンジ用収納容器および包装されたプレフィルドシリンジ |
| GB0619060D0 (en) | 2006-09-27 | 2006-11-08 | Glaxosmithkline Biolog Sa | Novel process |
| WO2008050837A1 (fr) | 2006-10-27 | 2008-05-02 | Otsuka Pharmaceutical Factory, Inc. | Solution médicamenteuse ayant une teneur réduite en oxygène dissous, procédé de production de cette solution et unité contant la solution médicamenteuse ayant une teneur réduite en oxygène dissous |
| JP5411422B2 (ja) | 2007-01-31 | 2014-02-12 | 関西電力株式会社 | バイポーラ型半導体装置、その製造方法およびツェナー電圧の制御方法 |
| US20080308444A1 (en) | 2007-06-13 | 2008-12-18 | Baxter International Inc. | Packaging system and method of alerting a practitioner |
| US8002737B2 (en) | 2007-10-04 | 2011-08-23 | Hyprotek, Inc. | Mixing/administration syringe devices, protective packaging and methods of protecting syringe handlers |
| JP5438896B2 (ja) | 2007-12-27 | 2014-03-12 | 大日本印刷株式会社 | プレフィルドシリンジ用の包装袋 |
| US8623401B2 (en) * | 2008-03-27 | 2014-01-07 | Fenwafe Inc. | Wafer formulation |
| FR2931681B1 (fr) | 2008-05-30 | 2011-11-25 | Becton Dickinson France | Seringue a embout universel |
| US9095324B2 (en) | 2008-06-20 | 2015-08-04 | Boston Scientific Scimed, Inc. | Package assembly |
| JP5587597B2 (ja) | 2008-12-19 | 2014-09-10 | 藤森工業株式会社 | 包装体 |
| JP5332958B2 (ja) | 2009-06-29 | 2013-11-06 | 大日本印刷株式会社 | プレフィルドシリンジ包装体及びプレフィルドシリンジ用パック |
| GB2471726B (en) | 2009-07-10 | 2013-09-11 | Oval Medical Technologies Ltd | A pre-filled syringe including an oxygen absorber |
| NZ596668A (en) | 2009-07-22 | 2013-09-27 | Gruenenthal Chemie | Oxidation-stabilized tamper-resistant dosage form |
| US9333288B2 (en) | 2011-09-30 | 2016-05-10 | Becton Dickinson France, S.A.S. | Attachable plunger rod and associated packaging |
| WO2014140095A1 (en) * | 2013-03-14 | 2014-09-18 | Becton Dickinson France S.A.S. | Injectable morphine formulations |
| PT2968729T (pt) | 2013-03-14 | 2018-11-06 | Fresenius Kabi Deutschland Gmbh | Sistema de acondicionamento para fármacos sensíveis ao oxigénio |
-
2014
- 2014-03-12 WO PCT/EP2014/054831 patent/WO2014140095A1/en not_active Ceased
- 2014-03-12 US US14/207,245 patent/US9072781B2/en active Active
- 2014-03-12 CA CA2902343A patent/CA2902343C/en active Active
- 2014-03-12 EP EP14710529.0A patent/EP2968132B1/en not_active Not-in-force
- 2014-03-12 JP JP2015562121A patent/JP6215970B2/ja active Active
- 2014-03-12 BR BR112015021586-6A patent/BR112015021586B1/pt active IP Right Grant
- 2014-03-12 AU AU2014230834A patent/AU2014230834B9/en active Active
- 2014-03-12 EP EP16188526.4A patent/EP3143988A1/en not_active Withdrawn
- 2014-03-14 CN CN201811072429.6A patent/CN109125254A/zh active Pending
- 2014-03-14 CN CN201410097764.7A patent/CN104042565A/zh active Pending
-
2015
- 2015-05-18 US US14/715,277 patent/US9192608B2/en active Active
- 2015-10-20 US US14/887,803 patent/US10213424B2/en active Active
-
2019
- 2019-02-11 US US16/272,108 patent/US20190167665A1/en not_active Abandoned
-
2020
- 2020-03-18 US US16/823,073 patent/US20200345720A1/en not_active Abandoned
-
2023
- 2023-04-28 US US18/309,069 patent/US20230414604A1/en not_active Abandoned
-
2024
- 2024-10-28 US US18/928,917 patent/US20250228846A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016512210A5 (enExample) | ||
| JP2018021007A5 (enExample) | ||
| ES2656901T3 (es) | Una formulación estabilizada de pemetrexed | |
| RU2013138672A (ru) | Способ, композиция и набор для чистки кишечника | |
| JP2015527385A5 (enExample) | ||
| JP2013545745A5 (enExample) | ||
| JP2015512952A5 (enExample) | ||
| RU2016147362A (ru) | Препараты жидкого концетрата циклофосфамида | |
| JP2015527402A5 (enExample) | ||
| FI4374878T3 (fi) | Karbetosiinia käsittävä farmaseuttinen koostumus | |
| JP2019081811A5 (enExample) | ||
| AR076864A1 (es) | Procedimiento y composicion para mejorar la absorcion de agentes terapeuticos | |
| JP2017509623A5 (enExample) | ||
| JP2015535243A5 (enExample) | ||
| WO2009033757A3 (en) | Use of mage-3 antigen (271-279) as a therapeutic agent | |
| FI3817751T3 (fi) | Vedettömän natriumtiosulfaatin formulaatioita | |
| JP2011026348A5 (enExample) | ||
| WO2012117257A8 (en) | Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer | |
| JP2017514924A5 (enExample) | ||
| JP2016503058A5 (enExample) | ||
| RU2016138577A (ru) | Жидкая фармцевтическая композиция | |
| JP2016530316A5 (enExample) | ||
| ES2605495T3 (es) | Solución de atomoxetina | |
| JP2017515888A5 (enExample) | ||
| JP2019537589A5 (enExample) |